HOB Biotech Group Corp.,Ltd (SHA:688656)

SHA:688656 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	377	391.86	382.83	311	309.16	214.93
Other Revenue	10.48	10.48	11.57	9.39	8.55	6.93
Revenue	387.48	402.34	394.41	320.39	317.71	221.86
Revenue Growth (YoY)	-3.44%	2.01%	23.10%	0.84%	43.20%	-14.38%
Cost of Revenue	155.01	145.16	149.41	118.14	98.55	76.4
Gross Profit	232.48	257.18	244.99	202.26	219.16	145.46
Selling, General & Admin	149.44	160.69	140.05	118.76	99.87	69.19
Research & Development	44.85	45.47	46.32	38.11	31.23	23.04
Other Operating Expenses	8	6.47	4.83	3.64	3.32	2.48
Operating Expenses	201.92	213.02	191.7	160.25	134.83	95.23
Operating Income	30.56	44.16	53.3	42.01	84.33	50.22
Interest Expense	-1.47	-2.71	-2.53	-1.92	-1.24	-1.89
Interest & Investment Income	0.31	0.89	3.4	6.95	13.08	15.3
Currency Exchange Gain (Loss)	-0.53	-0.53	-0.01	-0.15	-0.46	0.01
Other Non Operating Income (Expenses)	0.41	-0.36	-0.27	-0.18	0	-0
EBT Excluding Unusual Items	29.28	41.46	53.89	46.71	95.72	63.65
Gain (Loss) on Sale of Investments	-	-	0.43	0.22	0.01	-
Gain (Loss) on Sale of Assets	7.79	-0.75	0.03	-0.47	-0.08	-0.37
Asset Writedown	-1.1	-1.1	-	-	-	-
Other Unusual Items	1.44	1.43	2.28	0.02	3.48	1.82
Pretax Income	37.41	41.03	56.63	46.48	99.13	65.1
Income Tax Expense	0.98	4.23	9.29	4.83	12.93	8.49
Net Income	36.43	36.8	47.33	41.65	86.19	56.62
Net Income to Common	36.43	36.8	47.33	41.65	86.19	56.62
Net Income Growth	3.32%	-22.24%	13.64%	-51.68%	52.24%	-11.31%
Shares Outstanding (Basic)	62	62	63	63	62	47
Shares Outstanding (Diluted)	64	63	64	63	62	47
Shares Change (YoY)	1.31%	-0.79%	1.35%	2.50%	30.49%	-0.22%
EPS (Basic)	0.59	0.59	0.75	0.66	1.40	1.20
EPS (Diluted)	0.57	0.58	0.74	0.66	1.40	1.20
EPS Growth	1.98%	-21.62%	12.12%	-52.86%	16.67%	-11.11%
Free Cash Flow	-8.84	-54.15	-75.34	-161.9	-63.09	1.21
Free Cash Flow Per Share	-0.14	-0.85	-1.18	-2.56	-1.02	0.03
Dividend Per Share	0.300	0.300	0.400	0.300	0.530	0.300
Dividend Growth	-25.00%	-25.00%	33.33%	-43.40%	76.67%	-
Gross Margin	60.00%	63.92%	62.12%	63.13%	68.98%	65.56%
Operating Margin	7.89%	10.98%	13.51%	13.11%	26.54%	22.64%
Profit Margin	9.40%	9.15%	12.00%	13.00%	27.13%	25.52%
Free Cash Flow Margin	-2.28%	-13.46%	-19.10%	-50.53%	-19.86%	0.55%
EBITDA	74.22	83.31	86.41	68.95	104.06	65.62
EBITDA Margin	19.16%	20.71%	21.91%	21.52%	32.76%	29.58%
D&A For EBITDA	43.66	39.14	33.12	26.94	19.73	15.4
EBIT	30.56	44.16	53.3	42.01	84.33	50.22
EBIT Margin	7.89%	10.98%	13.51%	13.11%	26.54%	22.64%
Effective Tax Rate	2.62%	10.31%	16.41%	10.39%	13.05%	13.04%
Revenue as Reported	95.31	402.34	394.41	320.39	317.71	221.86
Advertising Expenses	-	10.05	9.61	8.73	6.51	5.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.